Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof: Patent #: 8,946,398

Judith Margarete Gottwein; Troels Kasper Hoyer  Scheel; Robert E Purcell; Jens Bukh

Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof: Patent #: 8,946,398

Judith Margarete Gottwein (Inventor), Troels Kasper Hoyer Scheel (Inventor), Robert E Purcell (Inventor), Jens Bukh (Inventor)

Abstract

The present invention relates to molecular approaches to the production of nucleic acid sequences, which comprises the genome of infectious hepatitis C virus. In particular, invention provides nucleic acid sequences which comprise the genomes of infectious hepatitis C viruses of either genotype 3a (strain S52) or genotype 4a (strain ED43). The invention therefore relates to the use of the nucleic acid sequences and polypeptides encoded by all or part of the sequences in the development of vaccines and diagnostic assays for HCV and in the development of screening assays for the identification of antiviral agents for HCV. The invention therefore also relates to the use of viral particles derived from laboratory animals infected with S52 and ED43 viruses.

Original language	English
IPC	C07H 21/04 (20060101); C07H 21/02 (20060101)
Patent number	WO2011/038737
Filing date	26/07/2012
Country/Territory	Denmark
Priority date	16/09/2010
Priority number	PCT/DK2010/050236
Publication status	Published - 3 Feb 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@misc{ca3c0cf3528546aeaa18a7d6b723d190,

title = "Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof: Patent #: 8,946,398 ",

abstract = "The present invention relates to molecular approaches to the production of nucleic acid sequences, which comprises the genome of infectious hepatitis C virus. In particular, invention provides nucleic acid sequences which comprise the genomes of infectious hepatitis C viruses of either genotype 3a (strain S52) or genotype 4a (strain ED43). The invention therefore relates to the use of the nucleic acid sequences and polypeptides encoded by all or part of the sequences in the development of vaccines and diagnostic assays for HCV and in the development of screening assays for the identification of antiviral agents for HCV. The invention therefore also relates to the use of viral particles derived from laboratory animals infected with S52 and ED43 viruses.",

author = "Gottwein, {Judith Margarete} and Scheel, {Troels Kasper Hoyer} and Purcell, {Robert E} and Jens Bukh",

year = "2015",

month = feb,

day = "3",

language = "English",

type = "Patent",

note = "WO2011/038737; C07H 21/04 (20060101); C07H 21/02 (20060101)",

}

TY - PAT

T1 - Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof

T2 - Patent #: 8,946,398

AU - Gottwein, Judith Margarete

AU - Scheel, Troels Kasper Hoyer

AU - Purcell, Robert E

AU - Bukh, Jens

PY - 2015/2/3

Y1 - 2015/2/3

N2 - The present invention relates to molecular approaches to the production of nucleic acid sequences, which comprises the genome of infectious hepatitis C virus. In particular, invention provides nucleic acid sequences which comprise the genomes of infectious hepatitis C viruses of either genotype 3a (strain S52) or genotype 4a (strain ED43). The invention therefore relates to the use of the nucleic acid sequences and polypeptides encoded by all or part of the sequences in the development of vaccines and diagnostic assays for HCV and in the development of screening assays for the identification of antiviral agents for HCV. The invention therefore also relates to the use of viral particles derived from laboratory animals infected with S52 and ED43 viruses.

AB - The present invention relates to molecular approaches to the production of nucleic acid sequences, which comprises the genome of infectious hepatitis C virus. In particular, invention provides nucleic acid sequences which comprise the genomes of infectious hepatitis C viruses of either genotype 3a (strain S52) or genotype 4a (strain ED43). The invention therefore relates to the use of the nucleic acid sequences and polypeptides encoded by all or part of the sequences in the development of vaccines and diagnostic assays for HCV and in the development of screening assays for the identification of antiviral agents for HCV. The invention therefore also relates to the use of viral particles derived from laboratory animals infected with S52 and ED43 viruses.

M3 - Patent

M1 - WO2011/038737

Y2 - 2012/07/26

ER -

Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof: Patent #: 8,946,398

Abstract

UN SDGs

Fingerprint

Cite this